极晚/晚期药物洗脱支架内血栓形成的发病机制及相关危险因素的研究进展
摘要
药物洗脱支架（DES）自2001年问世以来,明显降低金属裸支架（BMS）术后支架内再狭窄,但DES术后晚期（LST）及极晚期支架内血栓（VLST）形成引起了人们的注意,其可导致灾难性的临床后果甚至死亡,因而一直是DES设计和发展需要解决的主要问题之一。
出处
《实用医学杂志》
CAS
北大核心
2014年第21期3522-3524,共3页
The Journal of Practical Medicine
参考文献23
-
1Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in hu- mans delayed healing and late thrombot- ic risk [J]. J Am Coil Cardiol, 2006, 48(1) : 193-202.
-
2Lev EI, Leshem-Lev D, Mager A, et al. Circulating endothelial progenitorcell levels and function in patients who experienced late coronary stent thrombo- sis [Jl. EurHeartJ, 2010,31(21): 2625-2632.
-
3Butzal M, Loges S, Schweizer M, et al. Rapamycin inhibits proliferation and differentiation of human endothelial pro- genitor cells in vitro [J]. Exp Cell Res, 2004,300( 1 ) :65-71.
-
4Silber S, Da roman P, Klomp M, et al. Clinical results after coronary stenting with the GenousTM Bio-Engineered R StentTM : 12-month outcomes of the E-HEALING (Healthy Endothelial Ac- celerated Lining Inhibits Neointimal Growth) worldwide registry [J]. Eu- roIntervention, 2011,6(7) : 819-825.
-
5Lee JM, Choe W, Kim B, et al. Com- parison of endothelialization and neointi- mal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin [J]. Biomaterials, 2012,33(35) :8917-8927.
-
6Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents [J]. J Am Coll Cardiol, 2011,57 ( 11 ) : 1314-1322.
-
7Kang S, Lee CW, Song H, et al. OCT analysis in patients with very late stent thrombosis [J]. JACC Cardiovasc Imag- ing, 2013,6(6) :695-703.
-
8Karanasos A, Ligthart J, Witberg K, et al. Association of neointimal morphology by optical coherence tomography with rupture of neoatherosclerotic plaque very late after coronary stent implantation: SHE BiOS, 2013 [C]. International So- ciety for Optics and Photonics, 2013.
-
9Finn AV, Nakazawa G, Joner M, et al. Vaseular responses to drug eluting stents importance of delayed healing [J]. Arterioseler Thromb Vase Biol, 2007,27(7) : 1500-1510.
-
10Stefanini GG, Byrne RA, Serruys PW, et al. Biodegradable polymer drug-elut- ing stents reduce the risk of stent thrombosis at 4 years in patients under- going percutaneous coronary interven- tion: a pooled analysis of individual pa- tient data fi'om the ISAR-TEST 3, IS- AR-TEST 4, and LEADERS random- ized trials [J]. Eur Heart J, 2012,33 (10) : 1214-1222.
-
1裴汉军,吴永健,杨跃进.药物洗脱支架再狭窄治疗的研究进展[J].心血管病学进展,2013,34(2):174-177. 被引量：8
-
2谷臣锋,付秋玉,刘剑雄.冠状动脉药物洗脱支架内再狭窄研究进展[J].心血管病学进展,2017,38(1):70-73. 被引量：14
-
3Park DW,Park SW,Park KH,苗丽（摘译）,邓万俊（校）.长期随访药物洗脱支架置入术后支架内血栓形成的发生率及危险因素[J].心血管病学进展,2007,28(1):154-155.
-
4张晓红,马礼坤.极晚期支架内血栓的研究进展——发病机制及防治策略[J].心血管病学进展,2011,32(6):850-854. 被引量：2
-
5芮璐,强中强,王巍.药物洗脱支架术后晚期和晚晚期支架内血栓的发生机制[J].心血管病学进展,2013,34(4):474-478.
-
6鲍艳红,黄常新.放射性肺炎的发病机制及其防治研究进展[J].实用医学杂志,2015,31(21):3621-3623. 被引量：25
-
7丁荣晶,胡大一.药物洗脱支架置入术后晚期迟发血栓形成分析[J].中华内科杂志,2008,47(10):834-834.
-
8刘志涛,何国祥.冠状动脉支架内血栓与药物洗脱支架的安全性[J].心血管病学进展,2009,30(2):246-249. 被引量：6
-
9孟晓峰,石少林.CT在脊柱损伤诊断中的作用[J].实用医技杂志,2005,12(05B):1273-1274.
-
10朱伯谦,马根山.支架内再狭窄的治疗进展[J].东南大学学报（医学版）,2011,30(3):525-529. 被引量：6
